124 related articles for article (PubMed ID: 32220979)
1. PIP3 depletion rescues myoblast fusion defects in human rhabdomyosarcoma cells.
Lian YL; Chen KW; Chou YT; Ke TL; Chen BC; Lin YC; Chen L
J Cell Sci; 2020 Apr; 133(8):. PubMed ID: 32220979
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms regulating myoblast fusion: A multilevel interplay.
Lehka L; Rędowicz MJ
Semin Cell Dev Biol; 2020 Aug; 104():81-92. PubMed ID: 32063453
[TBL] [Abstract][Full Text] [Related]
3. Lnc-ORA interacts with microRNA-532-3p and IGF2BP2 to inhibit skeletal muscle myogenesis.
Cai R; Zhang Q; Wang Y; Yong W; Zhao R; Pang W
J Biol Chem; 2021; 296():100376. PubMed ID: 33548229
[TBL] [Abstract][Full Text] [Related]
4. Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration.
Park SY; Yun Y; Lim JS; Kim MJ; Kim SY; Kim JE; Kim IS
Nat Commun; 2016 Mar; 7():10871. PubMed ID: 26972991
[TBL] [Abstract][Full Text] [Related]
5. The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion.
Jiang C; Wang JH; Yue F; Kuang S
Dev Biol; 2016 Jan; 409(1):16-25. PubMed ID: 26586200
[TBL] [Abstract][Full Text] [Related]
6. Fine-Tuning of Piezo1 Expression and Activity Ensures Efficient Myoblast Fusion during Skeletal Myogenesis.
Ortuste Quiroga HP; Ganassi M; Yokoyama S; Nakamura K; Yamashita T; Raimbach D; Hagiwara A; Harrington O; Breach-Teji J; Asakura A; Suzuki Y; Tominaga M; Zammit PS; Goto K
Cells; 2022 Jan; 11(3):. PubMed ID: 35159201
[TBL] [Abstract][Full Text] [Related]
7. TIEG1 negatively controls the myoblast pool indispensable for fusion during myogenic differentiation of C2C12 cells.
Miyake M; Hayashi S; Iwasaki S; Uchida T; Watanabe K; Ohwada S; Aso H; Yamaguchi T
J Cell Physiol; 2011 Apr; 226(4):1128-36. PubMed ID: 20945337
[TBL] [Abstract][Full Text] [Related]
8. [Molecular regulation mechanism of
Zhu Y; Zhang JW; Qi J; Li XW; Chen L; Li MZ; Ma JD
Yi Chuan; 2019 Dec; 41(12):1110-1118. PubMed ID: 31857282
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase D1 facilitates second-phase myoblast fusion and skeletal muscle regeneration.
Teng S; Stegner D; Chen Q; Hongu T; Hasegawa H; Chen L; Kanaho Y; Nieswandt B; Frohman MA; Huang P
Mol Biol Cell; 2015 Feb; 26(3):506-17. PubMed ID: 25428992
[TBL] [Abstract][Full Text] [Related]
10. Suppression of protein kinase C theta contributes to enhanced myogenesis in vitro via IRS1 and ERK1/2 phosphorylation.
Marino JS; Hinds TD; Potter RA; Ondrus E; Onion JL; Dowling A; McLoughlin TJ; Sanchez ER; Hill JW
BMC Cell Biol; 2013 Sep; 14():39. PubMed ID: 24053798
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion kinase signaling regulates the expression of caveolin 3 and beta1 integrin, genes essential for normal myoblast fusion.
Quach NL; Biressi S; Reichardt LF; Keller C; Rando TA
Mol Biol Cell; 2009 Jul; 20(14):3422-35. PubMed ID: 19458188
[TBL] [Abstract][Full Text] [Related]
12. CD36 is required for myoblast fusion during myogenic differentiation.
Park SY; Yun Y; Kim IS
Biochem Biophys Res Commun; 2012 Nov; 427(4):705-10. PubMed ID: 23036201
[TBL] [Abstract][Full Text] [Related]
13. A novel in vitro model for the assessment of postnatal myonuclear accretion.
Kneppers A; Verdijk L; de Theije C; Corten M; Gielen E; van Loon L; Schols A; Langen R
Skelet Muscle; 2018 Feb; 8(1):4. PubMed ID: 29444710
[TBL] [Abstract][Full Text] [Related]
14. Genetic Mutations in jamb, jamc, and myomaker Revealed Different Roles on Myoblast Fusion and Muscle Growth.
Si Y; Wen H; Du S
Mar Biotechnol (NY); 2019 Feb; 21(1):111-123. PubMed ID: 30467785
[TBL] [Abstract][Full Text] [Related]
15. Divergent Regulation of Myotube Formation and Gene Expression by E2 and EPA during In-Vitro Differentiation of C2C12 Myoblasts.
Lacham-Kaplan O; Camera DM; Hawley JA
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979341
[TBL] [Abstract][Full Text] [Related]
16. Selective Targeting of Myoblast Fusogenic Signaling and Differentiation-Arrest Antagonizes Rhabdomyosarcoma Cells.
Granados VA; Avirneni-Vadlamudi U; Dalal P; Scarborough SR; Galindo KA; Mahajan P; Galindo RL
Cancer Res; 2019 Sep; 79(18):4585-4591. PubMed ID: 31331911
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion.
Hochreiter-Hufford AE; Lee CS; Kinchen JM; Sokolowski JD; Arandjelovic S; Call JA; Klibanov AL; Yan Z; Mandell JW; Ravichandran KS
Nature; 2013 May; 497(7448):263-7. PubMed ID: 23615608
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-4 affects myogenesis via Rac1-mediated actin remodeling and exhibits copy-number amplification and increased expression in human rhabdomyosarcoma tumors.
Szabo K; Varga D; Vegh AG; Liu N; Xiao X; Xu L; Dux L; Erdelyi M; Rovo L; Keller-Pinter A
Cell Mol Life Sci; 2022 Feb; 79(2):122. PubMed ID: 35128576
[TBL] [Abstract][Full Text] [Related]
19. Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation.
Contreras O; Villarreal M; Brandan E
Skelet Muscle; 2018 Feb; 8(1):5. PubMed ID: 29463296
[TBL] [Abstract][Full Text] [Related]
20. Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle.
Saab R; Spunt SL; Skapek SX
Curr Top Dev Biol; 2011; 94():197-234. PubMed ID: 21295688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
